| 1 |
Gamble LA, Grant RRC, Samaranayake SG, Fasaye GA, Koh C, Korman L, Asif B, Heller T, Hernandez JM, Blakely AM, Davis JL. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet 2023;60:241-6. [PMID: 35817563 DOI: 10.1136/jmg-2022-108733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Decourtye-Espiard L, Guilford P. Hereditary Diffuse Gastric Cancer. Gastroenterology 2023:S0016-5085(23)00110-5. [PMID: 36740198 DOI: 10.1053/j.gastro.2023.01.038] [Reference Citation Analysis]
|
| 3 |
Masiero M, Pravettoni G. Psychological Burden and Preferences in CDH1 Mutation Carriers: Beyond the Cancer Diagnosis. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_19] [Reference Citation Analysis]
|
| 4 |
Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O'Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lancet Oncol 2023;24:107-16. [PMID: 36509094 DOI: 10.1016/S1470-2045(22)00700-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Shah IH, Salo-Mullen EE, Amoroso KA, Kelsen D, Stadler ZK, Hamilton JG. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome. Hered Cancer Clin Pract 2022;20:31. [PMID: 36056367 DOI: 10.1186/s13053-022-00239-9] [Reference Citation Analysis]
|
| 6 |
Tutty E, Forbes Shepherd R, Hoskins C, Purvis R, Shanahan M, Boussioutas A, Forrest LE. Becoming and being a parent with an inherited predisposition to diffuse gastric cancer: A qualitative study of young adults with a CDH1 pathogenic variant. J Psychosoc Oncol 2022;:1-17. [PMID: 35959852 DOI: 10.1080/07347332.2022.2104676] [Reference Citation Analysis]
|
| 7 |
Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Hoskins C, Tutty E, Purvis R, Shanahan M, Boussioutas A, Forrest L. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management. J Genet Couns 2021. [PMID: 34265132 DOI: 10.1002/jgc4.1478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Liu Y, Calzone K, Fasaye GA, Quillin J. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'. J Genet Couns 2021;30:1091-104. [PMID: 33655597 DOI: 10.1002/jgc4.1393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Pappas A, Tan WK, Waldock W, Richardson S, Tripathi M, Januszewicz W, Roberts G, O'Donovan M, Fitzgerald RC, di Pietro M. Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial. Endoscopy 2021;53:246-53. [PMID: 32679601 DOI: 10.1055/a-1201-3125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
McGarragle KM, Hart TL, Swallow C, Brar S, Govindarajan A, Cohen Z, Aronson M. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy. Fam Cancer 2021;20:157-69. [PMID: 32754788 DOI: 10.1007/s10689-020-00197-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
LeBlanc S, Naveen D, Haan E, Barnett C, Rawlings L, Roscioli T, Poplawski N. CDH1-related blepharocheilodontic syndrome is associated with diffuse gastric cancer risk. Am J Med Genet A 2020;182:1780-4. [PMID: 32302040 DOI: 10.1002/ajmg.a.61601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 14 |
Laszkowska M, Silver ER, Schrope B, Kastrinos F, Wang TC, Hur C. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1. Clin Gastroenterol Hepatol 2020;18:822-829.e4. [PMID: 31220641 DOI: 10.1016/j.cgh.2019.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 15 |
Livon D, Moretta J, Noguès C. [What attitude to women at high risk of breast cancer?]. Presse Med 2019;48:1092-100. [PMID: 31706893 DOI: 10.1016/j.lpm.2019.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, Nagorney DM, Truty MJ, Grotz TE. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery 2019;166:547-55. [PMID: 31331685 DOI: 10.1016/j.surg.2019.04.036] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 17 |
Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol 2019; 25(23): 2878-2886 [PMID: 31249446 DOI: 10.3748/wjg.v25.i23.2878] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 18 |
Lynch HT, Nustas R, Kassim T, Snyder C, Shaw T, Diab O. The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. Cancer Genetics 2019;233-234:43-7. [DOI: 10.1016/j.cancergen.2019.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Hamilton JG, Long JM, Brandt AC, Brower J, Symecko H, Salo-Mullen EE, Christian SN, Harstad T, Couch FJ, Garber JE, Offit K, Robson ME, Domchek SM. Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing. JCO Precis Oncol 2019;3. [PMID: 31511843 DOI: 10.1200/PO.18.00300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, Lawton J. High-risk individuals' perceptions of reproductive genetic testing for CDH1 mutations. Fam Cancer 2017;16:531-5. [PMID: 28204904 DOI: 10.1007/s10689-017-9976-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 21 |
Ross E, Broer T, Kerr A, Cunningham-Burley S. Identity, community and care in online accounts of hereditary colorectal cancer syndrome. New Genet Soc 2018;37:117-36. [PMID: 29875617 DOI: 10.1080/14636778.2018.1469974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 22 |
Polom K, Marrelli D, D'Ignazio A, Roviello F. Hereditary diffuse gastric cancer: how to look for and how to manage it. Updates Surg. 2018;70:161-166. [PMID: 29869323 DOI: 10.1007/s13304-018-0545-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Mi EZ, Mi EZ, di Pietro M, O'Donovan M, Hardwick RH, Richardson S, Ziauddeen H, Fletcher PC, Caldas C, Tischkowitz M, Ragunath K, Fitzgerald RC. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Gastrointest Endosc 2018;87:408-18. [PMID: 28688938 DOI: 10.1016/j.gie.2017.06.028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 24 |
Zhang H, Feng M, Feng Y, Bu Z, Li Z, Jia S, Ji J. Germline mutations in hereditary diffuse gastric cancer. Chin J Cancer Res 2018;30:122-30. [PMID: 29545726 DOI: 10.21147/j.issn.1000-9604.2018.01.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 25 |
Roberts G, Hardwick R, Fitzgerald RC. Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations. Transl Gastroenterol Hepatol 2017;2:21. [PMID: 28447056 DOI: 10.21037/tgh.2017.03.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 26 |
López M, Cervera-Acedo C, Santibáñez P, Salazar R, Sola JJ, Domínguez-Garrido E. A novel mutation in the CDH1 gene in a Spanish family with hereditary diffuse gastric cancer. Springerplus 2016;5:1181. [PMID: 27512640 DOI: 10.1186/s40064-016-2852-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
